Fortrea
Update in progressFTRE (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Fortrea Holdings Inc. is a contract research organization delivering biopharmaceutical product and medical device development solutions to customers worldwide. It provides clinical pharmacology, bioanalysis, pharmacokinetics, modeling and simulation, study design and monitoring, data management, biostatistics, pharmacovigilance, medical writing, site start-up, patient recruitment, and end-to-end clinical development (Phases I–IV) plus real-world evidence. It also offers regulatory, market access, health economics, and outcomes research consulting and RWE services. Incorporated 2023, headquartered in Durham, North Carolina.
Company score
- Sentiment
- -0.02
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.02
- Governance
- -0.15
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.03
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!